Three-way approach for precision strike against pancreatic cancer
Cancer Pancreatic Cancer T Cell

Three-way approach for precision strike against pancreatic cancer

Alejandro Noval
Alejandro Noval

London researchers have developed a three-pronged strategy to tackle pancreatic cancer by combining a drug and viruses that target cancer cells with immune cells from the patients, modified to specifically attack pancreatic cancer cells.

In 10 seconds? Scientists have reported positive preliminary results in lab mice with pancreatic cancer using a combination of a drug, genetically engineered viruses and immune cells.

Try Sparrow today

  • Read the latest science updates in just three minutes
  • Get five Digests emailed to you every week—100% free
  • No angle. No agenda. Just the facts.
  • Premium subscribers get access to the complete Sparrow library